<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37175509</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Deciphering the Relationship between SARS-CoV-2 and Cancer.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7803</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24097803</ELocationID><Abstract><AbstractText>Some viruses are known to be associated with the onset of specific cancers. These microorganisms, oncogenic viruses or oncoviruses, can convert normal cells into cancer cells by modulating the central metabolic pathways or hampering genomic integrity mechanisms, consequently inhibiting the apoptotic machinery and/or enhancing cell proliferation. Seven oncogenic viruses are known to promote tumorigenesis in humans: human papillomavirus (HPV), hepatitis B and C viruses (HBV, HCV), Epstein-Barr virus (EBV), human T-cell leukemia virus 1 (HTLV-1), Kaposi sarcoma-associated herpesvirus (KSHV), and Merkel cell polyomavirus (MCPyV). Recent research indicates that SARS-CoV-2 infection and COVID-19 progression may predispose recovered patients to cancer onset and accelerate cancer development. This hypothesis is based on the growing evidence regarding the ability of SARS-CoV-2 to modulate oncogenic pathways, promoting chronic low-grade inflammation and causing tissue damage. Herein, we summarize the main relationships known to date between virus infection and cancer, providing a summary of the proposed biochemical mechanisms behind the cellular transformation. Mechanistically, DNA viruses (such as HPV, HBV, EBV, and MCPyV) encode their virus oncogenes. In contrast, RNA viruses (like HCV, HTLV-1) may encode oncogenes or trigger host oncogenes through cis-/-trans activation leading to different types of cancer. As for SARS-CoV-2, its role as an oncogenic virus seems to occur through the inhibition of oncosuppressors or controlling the metabolic and autophagy pathways in the infected cells. However, these effects could be significant in particular scenarios like those linked to severe COVID-19 or long COVID. On the other hand, looking at the SARS-CoV-2&#x2500;cancer relationship from an opposite perspective, oncolytic effects and anti-tumor immune response were triggered by SARS-CoV-2 infection in some cases. In summary, our work aims to recall comprehensive attention from the scientific community to elucidate the effects of SARS-CoV-2 and, more in general, &#x3b2;-coronavirus infection on cancer susceptibility for cancer prevention or supporting therapeutic approaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costanzo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6386-2009</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CEINGE-Biotecnologie Avanzate Franco Salvatore s.c.ar.l., Via G. Salvatore 486, 80145 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Giglio</LastName><ForeName>Maria Anna Rachele</ForeName><Initials>MAR</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roviello</LastName><ForeName>Giovanni Nicola</ForeName><Initials>GN</Initials><Identifier Source="ORCID">0000-0002-6978-542X</Identifier><AffiliationInfo><Affiliation>Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Via P. Castellino 111, 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030361" MajorTopicYN="Y">Papillomavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009858" MajorTopicYN="N">Oncogenic Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006526" MajorTopicYN="Y">Hepatitis C</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVIDomics</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">immune escape</Keyword><Keyword MajorTopicYN="N">immunotherapy</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">metabolic reprogramming</Keyword><Keyword MajorTopicYN="N">oncogenic virus</Keyword><Keyword MajorTopicYN="N">oncolytic virus</Keyword><Keyword MajorTopicYN="N">oncoviruses</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37175509</ArticleId><ArticleId IdType="pmc">PMC10178366</ArticleId><ArticleId IdType="doi">10.3390/ijms24097803</ArticleId><ArticleId IdType="pii">ijms24097803</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaimy M.A., Saffarzadeh N., Mohammadi A., Pourghadamyari H., Izadi P., Sarli A., Moghaddam L.K., Paschepari S.R., Azizi H., Torkamandi S., et al. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017;24:233&#x2013;243. doi: 10.1038/cgt.2017.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cgt.2017.16</ArticleId><ArticleId IdType="pubmed">28574057</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathi E., Thangavel C. Dark Side of Cancer Therapy: Cancer Treatment-Induced Cardiopulmonary Inflammation, Fibrosis, and Immune Modulation. Int. J. Mol. Sci. 2021;22:10126. doi: 10.3390/ijms221810126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221810126</ArticleId><ArticleId IdType="pmc">PMC8465322</ArticleId><ArticleId IdType="pubmed">34576287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotouhi S., Asadi S., Kattan M.W. A comprehensive data level analysis for cancer diagnosis on imbalanced data. J. Biomed. Inform. 2019;90:103089. doi: 10.1016/j.jbi.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.12.003</ArticleId><ArticleId IdType="pubmed">30611011</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbert A., Abel G.A., Winters S., McPhail S., Elliss-Brookes L., Lyratzopoulos G. Are inequalities in cancer diagnosis through emergency presentation narrowing, widening or remaining unchanged? Longitudinal analysis of English population-based data 2006&#x2013;2013. J. Epidemiol. Community Health. 2019;73:3&#x2013;10. doi: 10.1136/jech-2017-210371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2017-210371</ArticleId><ArticleId IdType="pmc">PMC6839789</ArticleId><ArticleId IdType="pubmed">30409920</ArticleId></ArticleIdList></Reference><Reference><Citation>Raab S.S., Grzybicki D.M. Quality in Cancer Diagnosis. CA Cancer J. Clin. 2010;60:139&#x2013;165. doi: 10.3322/caac.20068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.20068</ArticleId><ArticleId IdType="pubmed">20444999</ArticleId></ArticleIdList></Reference><Reference><Citation>Stingi A., Cirillo L. SARS-CoV-2 infection and cancer. BioEssays. 2021;43:2000289. doi: 10.1002/bies.202000289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000289</ArticleId><ArticleId IdType="pmc">PMC8209829</ArticleId><ArticleId IdType="pubmed">34081334</ArticleId></ArticleIdList></Reference><Reference><Citation>Arisi M., Zane C., Caravello S., Rovati C., Zanca A., Venturini M., Calzavara-Pinton P. Sun Exposure and Melanoma, Certainties and Weaknesses of the Present Knowledge. Front. Med. 2018;5:235. doi: 10.3389/fmed.2018.00235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00235</ArticleId><ArticleId IdType="pmc">PMC6126418</ArticleId><ArticleId IdType="pubmed">30214901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesri E.A., Feitelson M.A., Munger K. Human Viral Oncogenesis: A Cancer Hallmarks Analysis. Cell Host Microbe. 2014;15:266&#x2013;282. doi: 10.1016/j.chom.2014.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC3992243</ArticleId><ArticleId IdType="pubmed">24629334</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovan N., Duraisamy R., Desnues C. Metagenomics and the Human Virome in Asymptomatic Individuals. Annu. Rev. Microbiol. 2016;70:125&#x2013;141. doi: 10.1146/annurev-micro-102215-095431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-102215-095431</ArticleId><ArticleId IdType="pubmed">27607550</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang G., Bushman F.D. The human virome: Assembly, composition and host interactions. Nat. Rev. Microbiol. 2021;19:514&#x2013;527. doi: 10.1038/s41579-021-00536-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00536-5</ArticleId><ArticleId IdType="pmc">PMC8008777</ArticleId><ArticleId IdType="pubmed">33785903</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlecht-Louf G., Deback C., Bachelerie F. The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy. Cancers. 2022;14:848. doi: 10.3390/cancers14030848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14030848</ArticleId><ArticleId IdType="pmc">PMC8834488</ArticleId><ArticleId IdType="pubmed">35159113</ArticleId></ArticleIdList></Reference><Reference><Citation>de Martel C., Georges D., Bray F., Ferlay J., Clifford G.M. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis. Lancet Glob. Health. 2020;8:e180&#x2013;e190. doi: 10.1016/S2214-109X(19)30488-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(19)30488-7</ArticleId><ArticleId IdType="pubmed">31862245</ArticleId></ArticleIdList></Reference><Reference><Citation>zur Hausen H., de Villiers E.-M. Cancer &#x201c;Causation&#x201d; by Infections&#x2014;Individual Contributions and Synergistic Networks. Semin. Oncol. 2014;41:860&#x2013;875. doi: 10.1053/j.seminoncol.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminoncol.2014.10.003</ArticleId><ArticleId IdType="pubmed">25499643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempera I., Lieberman P.M. Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Front. Virol. 2021;1:753366. doi: 10.3389/fviro.2021.753366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fviro.2021.753366</ArticleId><ArticleId IdType="pmc">PMC8822580</ArticleId><ArticleId IdType="pubmed">35141704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mui U., Haley C., Tyring S. Viral Oncology: Molecular Biology and Pathogenesis. J. Clin. Med. 2017;6:111. doi: 10.3390/jcm6120111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm6120111</ArticleId><ArticleId IdType="pmc">PMC5742800</ArticleId><ArticleId IdType="pubmed">29186062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Li D. Searching for human oncoviruses: Histories, challenges, and opportunities. J. Cell. Biochem. 2018;119:4897&#x2013;4906. doi: 10.1002/jcb.26717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26717</ArticleId><ArticleId IdType="pubmed">29377246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaei H., Khodadad N., Karami C., Pirmoradi R., Khanizadeh S. The AP-1 pathway; A key regulator of cellular transformation modulated by oncogenic viruses. Rev. Med. Virol. 2019;30:e2008. doi: 10.1002/rmv.2088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2088</ArticleId><ArticleId IdType="pubmed">31788897</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Fiocchetti M., Ascenzi P., Marino M., Caterino M., Ruoppolo M. Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells. Molecules. 2021;26:2397. doi: 10.3390/molecules26082397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26082397</ArticleId><ArticleId IdType="pmc">PMC8074618</ArticleId><ArticleId IdType="pubmed">33924212</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Caterino M., Salvatori I., Manganelli V., Ferri A., Misasi R., Ruoppolo M. Proteome data of neuroblastoma cells overexpressing Neuroglobin. Data Brief. 2022;41:107843. doi: 10.1016/j.dib.2022.107843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2022.107843</ArticleId><ArticleId IdType="pmc">PMC8800053</ArticleId><ArticleId IdType="pubmed">35128003</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganelli V., Salvatori I., Costanzo M., Capozzi A., Caissutti D., Caterino M., Valle C., Ferri A., Sorice M., Ruoppolo M., et al. Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells. Cells. 2021;10:3394. doi: 10.3390/cells10123394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123394</ArticleId><ArticleId IdType="pmc">PMC8699457</ArticleId><ArticleId IdType="pubmed">34943907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rous P. A Transmissible Avian Neoplasm. (Sarcoma of the Common Fowl.) J. Exp. Med. 1910;12:696&#x2013;705. doi: 10.1084/jem.12.5.696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.12.5.696</ArticleId><ArticleId IdType="pmc">PMC2124810</ArticleId><ArticleId IdType="pubmed">19867354</ArticleId></ArticleIdList></Reference><Reference><Citation>zur Hausen H. Cancers in Humans: A Lifelong Search for Contributions of Infectious Agents, Autobiographic Notes. Annu. Rev. Virol. 2019;6:1&#x2013;28. doi: 10.1146/annurev-virology-092818-015907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092818-015907</ArticleId><ArticleId IdType="pubmed">31567062</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkitt D. A sarcoma involving the jaws in african children. Br. J. Surg. 1958;46:218&#x2013;223. doi: 10.1002/bjs.18004619704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.18004619704</ArticleId><ArticleId IdType="pubmed">13628987</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein M.A., Henle G., Achong B.G., Barr Y.M. Morphological and Biological Studies on a Virus in Cultured Lymphoblasts from Burkitt&#x2019;s Lymphoma. J. Exp. Med. 1965;121:761&#x2013;770. doi: 10.1084/jem.121.5.761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.121.5.761</ArticleId><ArticleId IdType="pmc">PMC2138004</ArticleId><ArticleId IdType="pubmed">14278230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pipas J.M., Sullivan C.S. DNA Tumor Viruses and Their Contributions to Molecular Biology. J. Virol. 2019;93:e01524-18. doi: 10.1128/JVI.01524-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01524-18</ArticleId><ArticleId IdType="pmc">PMC6475781</ArticleId><ArticleId IdType="pubmed">30814278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lion T. Adenovirus persistence, reactivation, and clinical management. FEBS Lett. 2019;593:3571&#x2013;3582. doi: 10.1002/1873-3468.13576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13576</ArticleId><ArticleId IdType="pubmed">31411731</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.-S., Ren H.-C., Cao J.-H. Correlation of SARS-CoV-2 to cancer: Carcinogenic or anticancer? (Review) Int. J. Oncol. 2022;60:42. doi: 10.3892/ijo.2022.5332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2022.5332</ArticleId><ArticleId IdType="pmc">PMC8923649</ArticleId><ArticleId IdType="pubmed">35234272</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol. Oncol. 2010;117:S5&#x2013;S10. doi: 10.1016/j.ygyno.2010.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2010.01.024</ArticleId><ArticleId IdType="pubmed">20304221</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham S.V. The human papillomavirus replication cycle, and its links to cancer progression: A comprehensive review. Clin. Sci. 2017;131:2201&#x2013;2221. doi: 10.1042/CS20160786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20160786</ArticleId><ArticleId IdType="pubmed">28798073</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari A., Chen Z., Burk R.D. Human Papillomavirus. Karger; Basel, Switzerland: 2014. Human Papillomavirus Genomics: Past, Present and Future; pp. 1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430864</ArticleId><ArticleId IdType="pubmed">24643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N., Egawa K., Griffin H., Doorbar J. Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia. Viruses. 2015;7:3863&#x2013;3890. doi: 10.3390/v7072802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7072802</ArticleId><ArticleId IdType="pmc">PMC4517131</ArticleId><ArticleId IdType="pubmed">26193301</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu T., B&#xfc;hler S., Bartenschlager R. Chronic viral hepatitis and its association with liver cancer. Biol. Chem. 2017;398:817&#x2013;837. doi: 10.1515/hsz-2017-0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2017-0118</ArticleId><ArticleId IdType="pubmed">28455951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandiera S., Billie Bian C., Hoshida Y., Baumert T.F., Zeisel M.B. Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma. Curr. Opin. Virol. 2016;20:99&#x2013;105. doi: 10.1016/j.coviro.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.09.010</ArticleId><ArticleId IdType="pmc">PMC5120759</ArticleId><ArticleId IdType="pubmed">27741441</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrscher C., Roingeard P., Blanchard E. Hepatitis B Virus Entry into Cells. Cells. 2020;9:1486. doi: 10.3390/cells9061486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9061486</ArticleId><ArticleId IdType="pmc">PMC7349259</ArticleId><ArticleId IdType="pubmed">32570893</ArticleId></ArticleIdList></Reference><Reference><Citation>Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J.F., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 2006;45:529&#x2013;538. doi: 10.1016/j.jhep.2006.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2006.05.013</ArticleId><ArticleId IdType="pubmed">16879891</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatun M., Ray R.B. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells. 2019;8:1249. doi: 10.3390/cells8101249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101249</ArticleId><ArticleId IdType="pmc">PMC6829586</ArticleId><ArticleId IdType="pubmed">31615075</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseem M., Barzi A., Brezden-Masley C., Puccini A., Berger M.D., Tokunaga R., Battaglin F., Soni S., McSkane M., Zhang W., et al. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat. Rev. 2018;66:15&#x2013;22. doi: 10.1016/j.ctrv.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC5964025</ArticleId><ArticleId IdType="pubmed">29631196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagaya Y., Gallo R.C. The Exceptional Oncogenicity of HTLV-1. Front. Microbiol. 2017;8:1425. doi: 10.3389/fmicb.2017.01425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01425</ArticleId><ArticleId IdType="pmc">PMC5539117</ArticleId><ArticleId IdType="pubmed">28824561</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites C., Grassi M.F., Quaresma J.A.S., Ishak R., Vallinoto A.C.R. Pathogenesis of HTLV-1 infection and progression biomarkers: An overview. Braz. J. Infect. Dis. 2021;25:101594. doi: 10.1016/j.bjid.2021.101594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2021.101594</ArticleId><ArticleId IdType="pmc">PMC9392164</ArticleId><ArticleId IdType="pubmed">34256025</ArticleId></ArticleIdList></Reference><Reference><Citation>Etta E., Alayande D., Mavhandu-Ramarumo L., Gachara G., Bessong P. HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998&#x2013;2017: A Systematic Review. Viruses. 2018;10:458. doi: 10.3390/v10090458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10090458</ArticleId><ArticleId IdType="pmc">PMC6164965</ArticleId><ArticleId IdType="pubmed">30150604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas J. Human Herpesvirus 8-Encoded Proteins with Potential Roles in Virus-Associated Neoplasia. Front. Biosci. 2007;12:265&#x2013;281. doi: 10.2741/2063.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2063</ArticleId><ArticleId IdType="pubmed">17127298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo V., Prezioso C., Moens U. Merkel Cell Polyomavirus and Merkel Cell Carcinoma. Cancers. 2020;12:1774. doi: 10.3390/cancers12071774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12071774</ArticleId><ArticleId IdType="pmc">PMC7407210</ArticleId><ArticleId IdType="pubmed">32635198</ArticleId></ArticleIdList></Reference><Reference><Citation>Krump N.A., You J. From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis. Front. Microbiol. 2021;12:739695. doi: 10.3389/fmicb.2021.739695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.739695</ArticleId><ArticleId IdType="pmc">PMC8457551</ArticleId><ArticleId IdType="pubmed">34566942</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groof T.W.M., Elder E.G., Siderius M., Heukers R., Sinclair J.H., Smit M.J., Schulte G. Viral G Protein&#x2013;Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases. Pharmacol. Rev. 2021;73:828&#x2013;846. doi: 10.1124/pharmrev.120.000186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pharmrev.120.000186</ArticleId><ArticleId IdType="pubmed">33692148</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitzman M.D., Fradet-Turcotte A. Virus DNA Replication and the Host DNA Damage Response. Annu. Rev. Virol. 2018;5:141&#x2013;164. doi: 10.1146/annurev-virology-092917-043534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092917-043534</ArticleId><ArticleId IdType="pmc">PMC6462412</ArticleId><ArticleId IdType="pubmed">29996066</ArticleId></ArticleIdList></Reference><Reference><Citation>Krump N.A., You J. Molecular mechanisms of viral oncogenesis in humans. Nat. Rev. Microbiol. 2018;16:684&#x2013;698. doi: 10.1038/s41579-018-0064-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0064-6</ArticleId><ArticleId IdType="pmc">PMC6336458</ArticleId><ArticleId IdType="pubmed">30143749</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales-S&#xe1;nchez A., Fuentes-Panan&#xe1; E.M. Human viruses and cancer. Viruses. 2014;6:4047&#x2013;4079. doi: 10.3390/v6104047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6104047</ArticleId><ArticleId IdType="pmc">PMC4213577</ArticleId><ArticleId IdType="pubmed">25341666</ArticleId></ArticleIdList></Reference><Reference><Citation>Adoue V., Joffre O. Les r&#xe9;trovirus endog&#xe8;nes. Med. Sci. 2020;36:253&#x2013;260. doi: 10.1051/medsci/2020022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1051/medsci/2020022</ArticleId><ArticleId IdType="pubmed">32228844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K.-W., Larsson E. Tumour virology in the era of high-throughput genomics. Philos. Trans. R. Soc. B Biol. Sci. 2017;372:20160265. doi: 10.1098/rstb.2016.0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0265</ArticleId><ArticleId IdType="pmc">PMC5597732</ArticleId><ArticleId IdType="pubmed">28893932</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z., Jhunjhunwala S., Liu J., Haverty P.M., Kennemer M.I., Guan Y., Lee W., Carnevali P., Stinson J., Johnson S., et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 2012;22:593&#x2013;601. doi: 10.1101/gr.133926.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.133926.111</ArticleId><ArticleId IdType="pmc">PMC3317142</ArticleId><ArticleId IdType="pubmed">22267523</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgui de Oliveira D. DNA viruses in human cancer: An integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett. 2007;247:182&#x2013;196. doi: 10.1016/j.canlet.2006.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2006.05.010</ArticleId><ArticleId IdType="pubmed">16814460</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchkovich N.J., Yu Y., Zampieri C.A., Alwine J.C. The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K&#x2013;Akt&#x2013;mTOR signalling pathway. Nat. Rev. Microbiol. 2008;6:266&#x2013;275. doi: 10.1038/nrmicro1855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1855</ArticleId><ArticleId IdType="pmc">PMC2597498</ArticleId><ArticleId IdType="pubmed">18311165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D., Weinberg R.A. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646&#x2013;674. doi: 10.1016/j.cell.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.013</ArticleId><ArticleId IdType="pubmed">21376230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaglia M.M., Munger K. More than just oncogenes: Mechanisms of tumorigenesis by human viruses. Curr. Opin. Virol. 2018;32:48&#x2013;59. doi: 10.1016/j.coviro.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2018.09.003</ArticleId><ArticleId IdType="pmc">PMC6405337</ArticleId><ArticleId IdType="pubmed">30268926</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin-Drubin M.E., Crum C.P., M&#xfc;nger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc. Natl. Acad. Sci. USA. 2011;108:2130&#x2013;2135. doi: 10.1073/pnas.1009933108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009933108</ArticleId><ArticleId IdType="pmc">PMC3033314</ArticleId><ArticleId IdType="pubmed">21245294</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgers W.A., Blanchon L., Pradhan S., Launoit Y.d., Kouzarides T., Fuks F. Viral oncoproteins target the DNA methyltransferases. Oncogene. 2006;26:1650&#x2013;1655. doi: 10.1038/sj.onc.1209950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209950</ArticleId><ArticleId IdType="pmc">PMC3350866</ArticleId><ArticleId IdType="pubmed">16983344</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., De Giglio M.A., Roviello G.N. SARS-CoV-2: Recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Curr. Med. Chem. 2020;27:4536&#x2013;4541. doi: 10.2174/0929867327666200416131117.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867327666200416131117</ArticleId><ArticleId IdType="pubmed">32297571</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi H., Mashouri L., Okpechi S.C., Alahari N., Alahari S.K. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Biochem. Pharmacol. 2021;183:114296. doi: 10.1016/j.bcp.2020.114296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.114296</ArticleId><ArticleId IdType="pmc">PMC7581400</ArticleId><ArticleId IdType="pubmed">33191206</ArticleId></ArticleIdList></Reference><Reference><Citation>Borbone N., Piccialli I., Falanga A.P., Piccialli V., Roviello G.N., Oliviero G. Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era. Int. J. Mol. Sci. 2022;23:4359. doi: 10.3390/ijms23084359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084359</ArticleId><ArticleId IdType="pmc">PMC9031702</ArticleId><ArticleId IdType="pubmed">35457177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci A., Roviello G.N. Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV. Life. 2023;13:402. doi: 10.3390/life13020402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13020402</ArticleId><ArticleId IdType="pmc">PMC9966545</ArticleId><ArticleId IdType="pubmed">36836758</ArticleId></ArticleIdList></Reference><Reference><Citation>Roviello V., Roviello G.N. Less COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds. Environ. Chem. Lett. 2022;20:7&#x2013;17. doi: 10.1007/s10311-021-01309-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10311-021-01309-5</ArticleId><ArticleId IdType="pmc">PMC8408569</ArticleId><ArticleId IdType="pubmed">34483793</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., De Giglio M.A., Roviello G.N. Anti-coronavirus vaccines: Past investigations on SARS-CoV-1 and MERS-CoV, the approved vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV-2 Infection. Curr. Med. Chem. 2022;29:4&#x2013;18. doi: 10.2174/0929867328666210521164809.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867328666210521164809</ArticleId><ArticleId IdType="pubmed">34355678</ArticleId></ArticleIdList></Reference><Reference><Citation>Damasceno D.H., Amaral A.A., Silva C.A., Sim&#xf5;es e Silva A.C. The impact of vaccination worldwide on SARS-CoV-2 infection: A review on vaccine mechanisms, results of clinical trials, vaccinal coverage and interactions with novel variants. Curr. Med. Chem. 2022;29:2673&#x2013;2690. doi: 10.2174/0929867328666210902094254.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867328666210902094254</ArticleId><ArticleId IdType="pubmed">34473613</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo V., Roviello G.N. The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines. 2023;11:333. doi: 10.3390/vaccines11020333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020333</ArticleId><ArticleId IdType="pmc">PMC9962013</ArticleId><ArticleId IdType="pubmed">36851210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosar B., Karagulleoglu Z.Y., Unal S., Ince A.T., Uncuoglu D.B., Tuncer G., Kilinc B.R., Ozkan Y.E., Ozkoc H.C., Demir I.N. SARS-CoV-2 mutations and their viral variants. Cytokine Growth Factor Rev. 2022;63:10&#x2013;22. doi: 10.1016/j.cytogfr.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8252702</ArticleId><ArticleId IdType="pubmed">34580015</ArticleId></ArticleIdList></Reference><Reference><Citation>Magazine N., Zhang T., Wu Y., McGee M.C., Veggiani G., Huang W. Mutations and evolution of the SARS-CoV-2 spike protein. Viruses. 2022;14:640. doi: 10.3390/v14030640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030640</ArticleId><ArticleId IdType="pmc">PMC8949778</ArticleId><ArticleId IdType="pubmed">35337047</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang R., Wang M., Wei G.-W. Mutations strengthened SARS-CoV-2 infectivity. J. Mol. Biol. 2020;432:5212&#x2013;5226. doi: 10.1016/j.jmb.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.07.009</ArticleId><ArticleId IdType="pmc">PMC7375973</ArticleId><ArticleId IdType="pubmed">32710986</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond E., Thieblemont C., Alran S., Faivre S. Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Target. Oncol. 2020;15:249&#x2013;259. doi: 10.1007/s11523-020-00721-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11523-020-00721-1</ArticleId><ArticleId IdType="pmc">PMC7243433</ArticleId><ArticleId IdType="pubmed">32445083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai M., Liu D., Liu M., Zhou F., Li G., Chen Z., Zhang Z., You H., Wu M., Zheng Q., et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020;10:783&#x2013;791. doi: 10.1158/2159-8290.CD-20-0422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0422</ArticleId><ArticleId IdType="pmc">PMC7309152</ArticleId><ArticleId IdType="pubmed">32345594</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Fu L., Liu X., Liu X.-a., Liang Y., Lv Y., Yang Z., Guo A., Chen Z., Li W., et al. Serum metabolomic abnormalities in survivors of non-severe COVID-19. Heliyon. 2022;8:e10473. doi: 10.1016/j.heliyon.2022.e10473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e10473</ArticleId><ArticleId IdType="pmc">PMC9433334</ArticleId><ArticleId IdType="pubmed">36065322</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T., Wang T. Metabolic Reprogramming in COVID-19. Int. J. Mol. Sci. 2021;22:11475. doi: 10.3390/ijms222111475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111475</ArticleId><ArticleId IdType="pmc">PMC8584248</ArticleId><ArticleId IdType="pubmed">34768906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiansyah M., Jasim S.A., Mohammad Pour Z.G., Athar S.S., Jeda A.S., Doewes R.I., Jalil A.T., Bokov D.O., Mustafa Y.F., Noroozbeygi M., et al. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism. J. Med. Virol. 2022;94:4611&#x2013;4627. doi: 10.1002/jmv.27929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27929</ArticleId><ArticleId IdType="pmc">PMC9350347</ArticleId><ArticleId IdType="pubmed">35689351</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Ma F., Yokota T., Garcia G., Palermo A., Wang Y., Farrell C., Wang Y.-C., Wu R., Zhou Z., et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2&#x2013;induced systemic toxicity. JCI Insight. 2021;6:e145027. doi: 10.1172/jci.insight.145027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.145027</ArticleId><ArticleId IdType="pmc">PMC7934846</ArticleId><ArticleId IdType="pubmed">33284134</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N., Nie M., Pang H., Wang B., Hu J., Meng X., Li K., Ran X., Long Q., Deng H., et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 2021;12:1618. doi: 10.1038/s41467-021-21907-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21907-9</ArticleId><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Caterino M., Fedele R., Cevenini A., Pontillo M., Barra L., Ruoppolo M. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. Int. J. Mol. Sci. 2022;23:2414. doi: 10.3390/ijms23052414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052414</ArticleId><ArticleId IdType="pmc">PMC8910221</ArticleId><ArticleId IdType="pubmed">35269564</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M., Gelzo M., Sol S., Fedele R., Annunziata A., Calabrese C., Fiorentino G., D&#x2019;Abbraccio M., Dell&#x2019;Isola C., Fusco F.M., et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci. Rep. 2021;11:2941. doi: 10.1038/s41598-021-82426-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82426-7</ArticleId><ArticleId IdType="pmc">PMC7859398</ArticleId><ArticleId IdType="pubmed">33536486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Wang C., Duan B., Yang P., Wu J., Zhang Q. Altered Lipid Profile in COVID-19 Patients and Metabolic Reprogramming. Front. Microbiol. 2022;13:863802. doi: 10.3389/fmicb.2022.863802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.863802</ArticleId><ArticleId IdType="pmc">PMC9133671</ArticleId><ArticleId IdType="pubmed">35633693</ArticleId></ArticleIdList></Reference><Reference><Citation>Borella R., De Biasi S., Paolini A., Boraldi F., Lo Tartaro D., Mattioli M., Fidanza L., Neroni A., Caro-Maldonado A., Meschiari M., et al. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur. J. Immunol. 2021;52:484&#x2013;502. doi: 10.1002/eji.202149481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202149481</ArticleId><ArticleId IdType="pubmed">34870329</ArticleId></ArticleIdList></Reference><Reference><Citation>Moolamalla S.T.R., Balasubramanian R., Chauhan R., Priyakumar U.D., Vinod P.K. Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach. Microb. Pathog. 2021;158:105114. doi: 10.1016/j.micpath.2021.105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105114</ArticleId><ArticleId IdType="pmc">PMC8321700</ArticleId><ArticleId IdType="pubmed">34333072</ArticleId></ArticleIdList></Reference><Reference><Citation>Goubran H., Stakiw J., Seghatchian J., Ragab G., Burnouf T. SARS-CoV-2 and cancer: The intriguing and informative cross-talk. Transfus. Apher. Sci. 2022;61:103488. doi: 10.1016/j.transci.2022.103488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2022.103488</ArticleId><ArticleId IdType="pmc">PMC9192107</ArticleId><ArticleId IdType="pubmed">35753906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-M., Kim H.M., Lee E.J., Jo H.J., Yoon Y., Lee N.-J., Son J., Lee Y.-J., Kim M.S., Lee Y.-P., et al. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea. Osong Public Health Res. Perspect. 2020;11:112&#x2013;117. doi: 10.24171/j.phrp.2020.11.3.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2020.11.3.02</ArticleId><ArticleId IdType="pmc">PMC7282421</ArticleId><ArticleId IdType="pubmed">32528816</ArticleId></ArticleIdList></Reference><Reference><Citation>Icard P., Lincet H., Wu Z., Coquerel A., Forgez P., Alifano M., Fournel L. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 2021;180:169&#x2013;177. doi: 10.1016/j.biochi.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7659517</ArticleId><ArticleId IdType="pubmed">33189832</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A.C., Davanzo G.G., Monteiro L.d.B., de Souza G.F., Muraro S.P., Virgilio-da-Silva J.V., Prodonoff J.S., Carregari V.C., de Biagi Junior C.A.O., Crunfli F., et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1&#x3b1;/Glycolysis-Dependent Axis. Cell Metab. 2020;32:498&#x2013;499. doi: 10.1016/j.cmet.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Policard M., Jain S., Rego S., Dakshanamurthy S. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Virus Res. 2021;301:198464. doi: 10.1016/j.virusres.2021.198464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198464</ArticleId><ArticleId IdType="pmc">PMC8163696</ArticleId><ArticleId IdType="pubmed">34058265</ArticleId></ArticleIdList></Reference><Reference><Citation>Santorelli L., Caterino M., Costanzo M. Dynamic Interactomics by Cross-Linking Mass Spectrometry: Mapping the Daily Cell Life in Postgenomic Era. OMICS J. Integr. Biol. 2022;26:633&#x2013;649. doi: 10.1089/omi.2022.0137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2022.0137</ArticleId><ArticleId IdType="pubmed">36445175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj K., Liu P., Leibowitz J.L., Kao C.C. The Coronavirus Endoribonuclease Nsp15 Interacts with Retinoblastoma Tumor Suppressor Protein. J. Virol. 2012;86:4294&#x2013;4304. doi: 10.1128/JVI.07012-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.07012-11</ArticleId><ArticleId IdType="pmc">PMC3318636</ArticleId><ArticleId IdType="pubmed">22301153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma-Lauer Y., Carbajo-Lozoya J., Hein M.Y., M&#xfc;ller M.A., Deng W., Lei J., Meyer B., Kusov Y., von Brunn B., Bairad D.R., et al. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc. Natl. Acad. Sci. USA. 2016;113:E5192&#x2013;E5201. doi: 10.1073/pnas.1603435113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1603435113</ArticleId><ArticleId IdType="pmc">PMC5024628</ArticleId><ArticleId IdType="pubmed">27519799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y., Laister R.C., Lemak A., Wu B., Tai E., Duan S., Lukin J., Sunnerhagen M., Srisailam S., Karra M., et al. Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat. Struct. Mol. Biol. 2008;15:1334&#x2013;1342. doi: 10.1038/nsmb.1521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1521</ArticleId><ArticleId IdType="pmc">PMC4075976</ArticleId><ArticleId IdType="pubmed">19043414</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng R.P., Lin Y., Ma W., Wu H., Lemmers B., Chung S., Parant J.M., Lozano G., Hakem R., Benchimol S. Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation. Cell. 2003;112:779&#x2013;791. doi: 10.1016/S0092-8674(03)00193-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(03)00193-4</ArticleId><ArticleId IdType="pubmed">12654245</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R. Molecular basis for ADP-ribose binding to the Mac1 domain of SARS-CoV-2 nsp3. Biochemistry. 2020;59:2608&#x2013;2615. doi: 10.1021/acs.biochem.0c00309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.0c00309</ArticleId><ArticleId IdType="pmc">PMC7341687</ArticleId><ArticleId IdType="pubmed">32578982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardozo C.M., Hainaut P. Viral strategies for circumventing p53: The case of severe acute respiratory syndrome coronavirus. Curr. Opin. Oncol. 2021;33:149&#x2013;158. doi: 10.1097/CCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC7924916</ArticleId><ArticleId IdType="pubmed">33405482</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Carballa A., Martin&#xf3;n-Torres F., Salas A. Is SARS-CoV-2 an oncogenic virus? J. Infect. 2022;85:573&#x2013;607. doi: 10.1016/j.jinf.2022.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.08.005</ArticleId><ArticleId IdType="pmc">PMC9361571</ArticleId><ArticleId IdType="pubmed">35961462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Li X., Kuang E. Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses. Autophagy. 2023;19:1055&#x2013;1069. doi: 10.1080/15548627.2022.2116677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2116677</ArticleId><ArticleId IdType="pmc">PMC10012907</ArticleId><ArticleId IdType="pubmed">36005882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X., Cai K., Li J., Yuan Z., Chen R., Xiao H., Xu C., Hu B., Qin Y., Ding B. Coronavirus subverts ER-phagy by hijacking FAM134B and ATL3 into p62 condensates to facilitate viral replication. Cell Rep. 2023;42:112286. doi: 10.1016/j.celrep.2023.112286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112286</ArticleId><ArticleId IdType="pmc">PMC9998290</ArticleId><ArticleId IdType="pubmed">36952345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Li Y., Huang F., Luo B., Yuan Y., Xia B., Ma X., Yang T., Yu F., et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-I. Proc. Natl. Acad. Sci. USA. 2021;118:e2024202118. doi: 10.1073/pnas.2024202118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti A., Hait N.C. Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain. J. Cancer. 2021;12:954&#x2013;964. doi: 10.7150/jca.50137.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.50137</ArticleId><ArticleId IdType="pmc">PMC7797661</ArticleId><ArticleId IdType="pubmed">33442395</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.G., Macleod K.F. Autophagy, cancer stem cells and drug resistance. J. Pathol. 2019;247:708&#x2013;718. doi: 10.1002/path.5222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5222</ArticleId><ArticleId IdType="pmc">PMC6668344</ArticleId><ArticleId IdType="pubmed">30570140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W., Liu X., Wang T., Liu F., Zhu A., Lin Y., Luo J., Ye F., He J., Zhao J., et al. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients. J. Med. Virol. 2021;93:582&#x2013;584. doi: 10.1002/jmv.26406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26406</ArticleId><ArticleId IdType="pmc">PMC7436726</ArticleId><ArticleId IdType="pubmed">32776556</ArticleId></ArticleIdList></Reference><Reference><Citation>Knack R., Hanada T.Z.B., Knack R.S., Dana S., Afonso G.L., Omena T., Mayr K., Knack R.S. SARS-CoV-2, a possible new oncovirus? Qeios. 2023. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.32388/7G3IND</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Zhang P., Zhang K., Huang C. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer. Biochim. Biophys. Acta-Rev. Cancer. 2021;1876:188634. doi: 10.1016/j.bbcan.2021.188634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2021.188634</ArticleId><ArticleId IdType="pubmed">34656687</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G., Aneja R. Cancer as a prospective sequela of long COVID-19. BioEssays. 2021;43:e2000331. doi: 10.1002/bies.202000331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Han C., Wang S., Fang P., Ma Z., Xu L., Yin R. Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy. J. Hematol. Oncol. 2019;12:86. doi: 10.1186/s13045-019-0770-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-019-0770-1</ArticleId><ArticleId IdType="pmc">PMC6714445</ArticleId><ArticleId IdType="pubmed">31462327</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves H., Kwok H.F. Recent advances in the field of anti-cancer immunotherapy. BBA Clin. 2015;3:280&#x2013;288. doi: 10.1016/j.bbacli.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbacli.2015.04.001</ArticleId><ArticleId IdType="pmc">PMC4661591</ArticleId><ArticleId IdType="pubmed">26673349</ArticleId></ArticleIdList></Reference><Reference><Citation>Chulpanova D.S., Kitaeva K.V., Green A.R., Rizvanov A.A., Solovyeva V.V. Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy. Front. Cell Dev. Biol. 2020;8:402. doi: 10.3389/fcell.2020.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00402</ArticleId><ArticleId IdType="pmc">PMC7283917</ArticleId><ArticleId IdType="pubmed">32582698</ArticleId></ArticleIdList></Reference><Reference><Citation>Krekorian M., Fruhwirth G.O., Srinivas M., Figdor C.G., Heskamp S., Witney T.H., Aarntzen E.H. Imaging of T-cells and their responses during anti-cancer immunotherapy. Theranostics. 2019;9:7924. doi: 10.7150/thno.37924.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.37924</ArticleId><ArticleId IdType="pmc">PMC6814447</ArticleId><ArticleId IdType="pubmed">31656546</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M.H. Anti-cancer immunotherapy: Breakthroughs and future strategies. Semin. Immunopathol. 2019;41:1&#x2013;3. doi: 10.1007/s00281-018-0711-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0711-z</ArticleId><ArticleId IdType="pubmed">30242450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal M., Guo J., He P., Zhou D. Recent advances of oncolytic virus in cancer therapy. Hum. Vaccines Immunother. 2020;16:2389&#x2013;2402. doi: 10.1080/21645515.2020.1723363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1723363</ArticleId><ArticleId IdType="pmc">PMC7644205</ArticleId><ArticleId IdType="pubmed">32078405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao G.-d., He X.-b., Sun Q., Chen S., Wan K., Xu X., Feng X., Li P.-p., Chen B., Xiong M.-m. The Oncolytic Virus in Cancer Diagnosis and Treatment. Front. Oncol. 2020;10:1786. doi: 10.3389/fonc.2020.01786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01786</ArticleId><ArticleId IdType="pmc">PMC7509414</ArticleId><ArticleId IdType="pubmed">33014876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W., Li L., Zhou S., Qiu L., Qian Z., Zhang H., Zhao P. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response. J. Drug Target. 2020;28:982&#x2013;990. doi: 10.1080/1061186X.2020.1766473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2020.1766473</ArticleId><ArticleId IdType="pubmed">32379004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Kang X., Chen K.S., Jehng T., Jones L., Chen J., Huang X.F., Chen S.-Y. An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses. Nat. Commun. 2020;11:1395. doi: 10.1038/s41467-020-15229-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15229-5</ArticleId><ArticleId IdType="pmc">PMC7070065</ArticleId><ArticleId IdType="pubmed">32170083</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin F., Calveri M.M., Pizzarelli G., Calabrese A., Andreoli M., Bongiovanni I., Cattaneo C., Rignanese G. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma. Acta Bio Med. Atenei Parm. 2020;91:e2020047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716983</ArticleId><ArticleId IdType="pubmed">32921739</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727&#x2013;11734. doi: 10.1073/pnas.2003138117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Duijf P.H.G., Fl&#xf3;rez de Sessions P. Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19. mSystems. 2020;5:e00741-20. doi: 10.1128/mSystems.00741-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00741-20</ArticleId><ArticleId IdType="pmc">PMC7470988</ArticleId><ArticleId IdType="pubmed">32873611</ArticleId></ArticleIdList></Reference><Reference><Citation>Challenor S., Tucker D. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br. J. Haematol. 2021;192:415. doi: 10.1111/bjh.17116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17116</ArticleId><ArticleId IdType="pubmed">33386647</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Melo M., Remacle N., Cudr&#xe9;-Cung H.P., Roux C., Poms M., Cudalbu C., Barroso M., Gersting S.W., Feichtinger R.G., Mayr J.A., et al. The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery. Mol. Genet. Metab. 2021;133:157&#x2013;181. doi: 10.1016/j.ymgme.2021.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2021.03.017</ArticleId><ArticleId IdType="pubmed">33965309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Melo M., Fontana A.O., Viertl D., Allenbach G., Prior J.O., Rotman S., Feichtinger R.G., Mayr J.A., Costanzo M., Caterino M., et al. A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I. Mol. Genet. Metab. 2021;134:287&#x2013;300. doi: 10.1016/j.ymgme.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2021.10.003</ArticleId><ArticleId IdType="pubmed">34799272</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Shi F., Yang L., Liao W., Cao Y. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications. Biochim. Biophys. Acta (BBA)&#x2014;Rev. Cancer. 2022;1877:188724. doi: 10.1016/j.bbcan.2022.188724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2022.188724</ArticleId><ArticleId IdType="pubmed">35314213</ArticleId></ArticleIdList></Reference><Reference><Citation>Roviello G.N., Roviello G., Musumeci D., Capasso D., Di Gaetano S., Costanzo M., Pedone C. Synthesis and supramolecular assembly of 1,3-bis(1&#x2019;-uracilyl)-2-propanone. RSC Adv. 2014;4:28691&#x2013;28698. doi: 10.1039/c4ra03713h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ra03713h</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Caterino M., Ruoppolo M. Targeted metabolomics. In: Troisi J., editor. Metabolomics Perspectives. Elsevier; Amsterdam, The Netherlands: 2022. pp. 219&#x2013;236.</Citation></Reference><Reference><Citation>Di Minno A., Gelzo M., Caterino M., Costanzo M., Ruoppolo M., Castaldo G. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine. Int. J. Mol. Sci. 2022;23:5213. doi: 10.3390/ijms23095213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23095213</ArticleId><ArticleId IdType="pmc">PMC9103094</ArticleId><ArticleId IdType="pubmed">35563604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A., Sabatello M., Eyal G., Lee S.S.-J., Rowe J.W., Stiles D.F., Swanson A., Appelbaum P.S. Is precision medicine relevant in the age of COVID-19? Genet. Med. 2021;23:999&#x2013;1000. doi: 10.1038/s41436-020-01088-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-01088-4</ArticleId><ArticleId IdType="pmc">PMC7804584</ArticleId><ArticleId IdType="pubmed">33442027</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Caterino M., Sotgiu G., Ruoppolo M., Franconi F., Campesi I. Sex differences in the human metabolome. Biol. Sex Differ. 2022;13:30. doi: 10.1186/s13293-022-00440-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-022-00440-4</ArticleId><ArticleId IdType="pmc">PMC9199320</ArticleId><ArticleId IdType="pubmed">35706042</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S.-L., Wang X.-M., Feng Y.-G., Kang P.-M., Li Q.-Y., Sun T.-Y., Tan Q.-Y., Deng B. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer? Med. Hypotheses. 2020;143:110074. doi: 10.1016/j.mehy.2020.110074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110074</ArticleId><ArticleId IdType="pmc">PMC7333600</ArticleId><ArticleId IdType="pubmed">32645661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>